presents research examining the effectiveness of the MCMI to diagnose personality disorders and clinical syndromes as well as its diagnostic use with specific populations, including substance abusers, individuals with PTSD, individuals with eating disorders, spouse abusers, and prisoners.
In addition to the widely known and used MCMI specific to adults, Millon has also developed additional instruments, which are increasingly being used. These include inventories for adolescents (the Millon Adolescent Clinical Inventory [MACI] ), medical patients (Millon Behavioral Health Inventory [MBHI]), and nonpsychiatric patients (the Personality Adjective Check List [PACL] ). The fmal chapter describes the newest ofthe Millon Inventories, the Millon Index ofPersonality Styles (MIPS), which attempts to measure "personal styles" of adults free of psychiatric problems.
The Millon Inventories: Clinical and Personality Assessment is a reference text in the true sense of the term. It is not a book to be read from cover to cover but rather is the authoritative source on these inventories, which will serve as an excellent reference work. It is very well-written, and the editor has chosen well-published contributors. The book is physically attractive in both its binding and typeset. The price is reasonable given the completeness ofthe material. It will be ofinterest primarily to psychologists who work in the area of objective psychometric assessment and those engaged in research in personality and psychopathology.
Biological Psychiatry
Antidepressants: New Pharmacological Strategies. Phil Skolnick, editor. Totowa (NJ): Humana Press; 1997.267 p. US$99.50.
Review by

Martin AIda, MD
Halifax, Nova Scotia
This book was published in the Contemporary Neuroscience series. It is a collection of 13 papers covering various topics ranging from the role of selective serotonin reuptake inhibitors (SSRIs) to effects of antidepressants on gene expression. The premise of the book is that much research into mechanisms of depression and its treatment has focused on synaptic mechanisms involving serotonin and norepinephrine. While their role in antidepressant action is well-known, it does not explain the whole story. The goal of this publication is to offer alternative explanations of antidepressant mechanisms and suggest new mechanisms that could lead to the development of improved treatments for depression.
The first 3 chapters deal with serotonergic mechanisms at the receptor level, specifically the use of5HT lA antagonists to potentiate the effects of SSRIs, review serotoninnoradrenaline reuptake inhibitors, and present original work on 5HT-moduline by Fillion and others. 5HT-moduline, a small tetrapeptide, appears to control the release of serotonin through interaction with 5HT 1B receptors. It might be stimulated by acute stress, and the authors propose that it might playa role in placebo response in depression, among other effects.
The subsequent 2 chapters cover reversible monoamine oxidase inhibitors (RIMA) and calcium channel blockers. The chapter on calcium antagonists is an especially good review of the relevant literature.
The individual contributions are rather varied. Some present experimental data, some are literature reviews. Most chapters are very good and fulfil the objective ofthe book; for instance, the reviews of the role of N-methyl-D-aspartate (NMDA) in antidepressant action by Ian Paul and by Nuo-Yu Huang and others; also, the chapter on sigma receptors by Brian Leonard. Other chapters, such as the one on RIMA, are standard and bring relatively little in terms ofnew approaches to the treatment of depression.
Well-written and useful is the section on cAMP response element binding protein (CREB) and antidepressant action. This and the following part, "Antidepressants: Beyond the Synapse," present the most recent findings on signal transduction and molecular mechanisms. These are also the areas to which the subtitle "New Pharmacological Strategies" applies the most. Novel animal models will be needed to identify novel treatments, but the relevant chapter deals only with properties of the chronic mild stress model.
A premise commonly mentioned in the book is that of delayed action of antidepressants and the need to fmd a fasteracting treatment. While this is well-accepted in both the clinical and research communities, some recent studies seem to indicate that the time course ofimprovement in depression may be independent oftreatment modality, with responders showing an improvement early in the course oftreatment (1). Ifthis is indeed confirmed, our view of psychobiology of depression and antidepressant response may change significantly.
The book will be appreciated mainly by psychopharmacologists and other specialists looking for specific information. It may also be a useful reminder for clinicians or residents about the complexity of mood regulation and antidepressant action. It is not meant to be a comprehensive review or a textbook.
The book comes in a plastic cover. It is edited carefully, with no noticeable print errors. Principles ofNeuropsychopharmacology is the successor of the 1984 Fundamentals of Neuropsychopharmacology, published by 2 ofthe 3 authors of this new expanded and updated version ofan outstanding very specific textbook. As indicated by the authors in the preface, this is not a second edition, because it differs from the previous book in profound ways that reflect the revolutionary changes in this field. The third author (JSM) was added because ofhis expertise in neurochemistry.
Principles of
As a textbook, it is by far the most user-friendly currently available. It is divided into 4 major sections: Basic Concepts, Neurotransmitter Systems, Major Drug Classes, and Clinical Applications. Each section is further divided into comprehensive chapters. Chapters are standardized, and there is hardly any overlap (a problem that routinely plagues other multiauthored texts). The book is nicely formatted and very accessible. Subheadings are printed in a pleasant, reddish. brown tint, tables and graphs are highlighted, and the text is easy to read and to follow. Overall, the contents ofmost chap. ters are extremely comprehensive and up-to-date, with refer. ences well into 1995.
I was particularly impressed with the chapter on methods in neuropsychopharmacology, which includes a range of techniques from in situ hybridization to positron emission to. mography and techniques in behavioural pharmacology. The chapters on the different Neurotransmitter Systems are also masterfully composed. Each starts with a historical back. ground, followed by synthesis, storage, release, and thenthe current classification systems of receptor subtypes inclUding the mechanism underlying the functional-clinical relevance of these subtypes. The chapters are comprehensive beyond any other review or text available. I also found the chapters on the major drug classes and on the clinical applications ex· tremely useful.
The table of contents is very detailed and easy to follow, and the index is particularly well-constructed, including cross-references for the generic and the commercial names of drugs.
In the way the book is structured, it serves not only asatext for courses in psychopharmacology at both the undergraduate and graduate levels but also as a source for students, teachers, clinicians, and researchers from various disciplines including pharmacology, neurology, psychiatry, experimental psychei ogy, and nursing. This textbook is highly recommended.
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